Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS9 | O00182 | 1/20 | 0.37 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.37 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.37 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.37 |
| ▸ | TYMP | P19971 | 12/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | NT5E | P21589 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10017428 | 1.00 | LGALS9 (0.37) | LGALS9LGALS1LGALS3LGALS7; LGALS7BTYMP | |
| SCHEMBL15849784 | 1.00 | LGALS9 (0.37) | LGALS9LGALS1LGALS3LGALS7; LGALS7BTYMP | |
| SCHEMBL2786937 | 1.00 | LGALS9 (0.37) | LGALS9LGALS1LGALS3LGALS7; LGALS7BTYMP | |
| SCHEMBL2786934 | 1.00 | LGALS9 (0.37) | LGALS9LGALS1LGALS3LGALS7; LGALS7BTYMP | |
| SCHEMBL2786939 | 1.00 | LGALS9 (0.37) | LGALS9LGALS1LGALS3LGALS7; LGALS7BTYMP | |
| SCHEMBL2787153 | 0.88 | LGALS9 (0.34) | LGALS9LGALS1LGALS3LGALS7; LGALS7BTYMP | |
| SCHEMBL15849800 | 0.88 | ALDH1A1 (0.35) | LGALS9LGALS1LGALS3LGALS7; LGALS7BTYMP | |
| SCHEMBL10017427 | 0.88 | ALDH1A1 (0.35) | LGALS9LGALS1LGALS3LGALS7; LGALS7BTYMP | |
| SCHEMBL2787154 | 0.88 | LGALS9 (0.34) | LGALS9LGALS1LGALS3LGALS7; LGALS7BTYMP | |
| SCHEMBL10017419 | 0.88 | LGALS9 (0.34) | LGALS9LGALS1LGALS3LGALS7; LGALS7BTYMP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090124797-A1 | NOVEL SYNTHESIS OF BETA-NUCLEOSIDES | PHARMAESSENTIA CORPORATION (TW) | 2009-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124797-A1 | NOVEL SYNTHESIS OF BETA-NUCLEOSIDES | DUT, DCTD, UMPS | LGALS9 2596/4885LGALS1 4006/4885LGALS3 4431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.